Cited by 72Genetic Associations and EpidemiologyGenetic Mapping and Diversity in Plants and AnimalsDiabetes and associated disorders

Two-stage association study to identify the genetic susceptibility of a novel common variant of rs2075290 in ZPR1 to type 2 diabetes

Open access
Guan, Fanglin, Niu, Yu, Zhang, Tianxiao, Liu, Songfang, Ma, Lei, Qi, Ting, Feng, Jia, Zuo, Hong +3 more·2016·Scientific Reports

Abstract

The SNP of rs964184 in ZPR1 has recently been associated with type 2 diabetes mellitus (T2DM) in Japanese individuals. To comprehensively investigate the association of common variants in ZPR1 with T2DM in Han Chinese individuals, we designed a two-stage case-control study of 3,505 T2DM patients and 6,911 unrelated healthy Han Chinese individuals. A total of 24 single nucleotide polymorphisms (SNPs) were genotyped and single-SNP association, imputation and gender-specific association analyses were performed. To increase the coverage of genetic markers, we implemented imputation techniques to extend the number of tested makers to 280. A novel SNP, rs2075290 and the previously reported SNP, rs964184, were significantly associated with T2DM in the two independent datasets and individuals harboring the CC genotype of rs2075290 and GG genotype of rs964184 exhibited higher levels of fasting plasma glucose (FPG) and blood hemoglobin A1c (HbA1c) than individuals of other genotypes. Additionally, haplotype analyses indicated that two haplotype blocks containing rs2075290 or rs964184 were also significantly associated with T2DM. In summary, these results suggest that ZPR1 plays an important role in the etiology of T2DM and this gene might be involved in abnormal glucose metabolism.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep29586

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ZPR1/ZNF259 promoter region has the binding sequence for PPARs, which may activate genes involved in glucose and cholesterol metabolism, including APOE, via hepatocyte nuclear factor 4 alpha activation.

    “ZPR1/ZNF259 promoter region has the binding sequence for PPARs, which may activate genes involved in glucose and cholesterol metabolism, including APOE, via hepatocyte nuclear factor 4 alpha activation [39].”

    From Genome-wide analysis identifies novel loci influencing plasma apolipoprotein E concentration and Alzheimer’s disease risk (2023) · cites this paper as [39]

    The paper’s introductory passage (indexed under Abstract; no page number provided) says the ZPR1/ZNF259 promoter binds PPARG proteins 1 and 2, which bind HNF4α; it says HNF4α activates genes involved in glucose and cholesterol metabolism. It does not identify APOE as one of those genes. The Discussion mentions a different gene, APOA5, adjacent to ZPR1. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • rs964184 has been associated with triglycerides, type 2 diabetes, and abdominal aortic aneurysm.

    “has been associated with triglycerides [39, 40], type 2 diabetes [39] and abdominal aortic aneurysm (AAA) [41].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Danaei G.. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378, 31– 40, doi: 10.1016/s0140-6736(11)60679-x (2011). 21705069 · DOI · Paper page
  2. Yang W.. Prevalence of diabetes among men and women in China. N Engl J Med 362, 1090– 1101, doi: 10.1056/NEJMoa0908292 (2010). 20335585 · DOI · Paper page
  3. Xu Y.. Prevalence and control of diabetes in Chinese adults. JAMA 310, 948– 959, doi: 10.1001/jama.2013.168118 (2013). 24002281 · DOI
  4. Wild S., Roglic G., Green A., Sicree R. & King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047– 1053 (2004). 15111519
  5. Unoki H.. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 40, 1098– 1102, doi: 10.1038/ng.208 (2008). 18711366 · DOI · Paper page
  6. Yamauchi T.. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet 42, 864– 868, doi: 10.1038/ng.660 (2010). 20818381 · DOI
  7. Kooner J. S.. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 43, 984– 989, doi: 10.1038/ng.921 (2011). 21874001 PMC3773920 · DOI
  8. Cho Y. S.. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44, 67– 72, doi: 10.1038/ng.1019 (2012). 22158537 PMC3582398 · DOI
  9. Perry J. R.. Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. Plos Genet 8, e1002741, doi: 10.1371/journal.pgen.1002741 (2012). 22693455 PMC3364960 · DOI
  10. Morris A. P.. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44, 981– 990, doi: 10.1038/ng.2383 (2012). 22885922 PMC3442244 · DOI · Paper page
  11. Imamura M.. A single-nucleotide polymorphism in ANK1 is associated with susceptibility to type 2 diabetes in Japanese populations. Hum Mol Genet 21, 3042– 3049, doi: 10.1093/hmg/dds113 (2012). 22456796 · DOI
  12. Hara K.. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum Mol Genet 23, 239– 246, doi: 10.1093/hmg/ddt399 (2014). 23945395 · DOI
  13. Tsai F. J.. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. Plos Genet 6, e1000847, doi: 10.1371/journal.pgen.1000847 (2010). 20174558 PMC2824763 · DOI
  14. Shu X. O.. Identification of new genetic risk variants for type 2 diabetes. Plos Genet 6, e1001127, doi: 10.1371/journal.pgen.1001127 (2010). 20862305 PMC2940731 · DOI
  15. Prokopenko I., McCarthy M. I. & Lindgren C. M. Type 2 diabetes: new genes, new understanding. Trends Genet 24, 613– 621, doi: 10.1016/j.tig.2008.09.004 (2008). 18952314 PMC7116807 · DOI · Paper page
  16. McCarthy M. I. G, type 2 diabetes, and obesity. N Engl J Med 363, 2339– 2350, doi: 10.1056/NEJMra0906948 (2010). 21142536 · DOI · Paper page
  17. Tokoro F.. Association of a genetic variant of the ZPR1 zinc finger gene with type 2 diabetes mellitus. Biomed Rep 3, 88– 92, doi: 10.3892/br.2014.379 (2015). 25469254 PMC4251148 · DOI
  18. Galcheva-Gargova Z.. The cytoplasmic zinc finger protein ZPR1 accumulates in the nucleolus of proliferating cells. Mol Biol Cell 9, 2963– 2971 (1998). 9763455 PMC25573
  19. Galcheva-Gargova Z.. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science 272, 1797– 1802 (1996). 8650580
  20. Mangelsdorf D. J.. The nuclear receptor superfamily: the second decade. Cell 83, 835– 839 (1995). 8521507 PMC6159888
  21. Corton J. C., Anderson S. P. & Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol 40, 491– 518, doi: 10.1146/annurev.pharmtox.40.1.491 (2000). 10836145 · DOI
  22. Sladek F. M., Zhong W. M., Lai E. & Darnell J. E. Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 4, 2353– 2365 (1990). 2279702
  23. Nielsen D. M., Ehm M. G. & Weir B. S. Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am J Hum Genet 63, 1531– 1540 (1998). 9867708 PMC1377570
  24. Marchini J. & Howie B. Genotype imputation for genome-wide association studies. Nat Rev Genet 11, 499– 511, doi: 10.1038/nrg2796 (2010). 20517342 · DOI
  25. Kraja A. T.. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 60, 1329– 1339, doi: 10.2337/db10-1011 (2011). 21386085 PMC3064107 · DOI
  26. O’Brien P. J.. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51, 351– 359, doi: 10.1373/clinchem.2004.040824 (2005). 15528295 · DOI
  27. Aung L. H.. Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. J Cell Mol Med 18, 1417– 1428, doi: 10.1111/jcmm.12291 (2014). 24780069 PMC4124025 · DOI
  28. Talmud P. J.. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia 49, 2337– 2340, doi: 10.1007/s00125-006-0387-0 (2006). 16917759 · DOI
  29. Sóter M. O.. −1131T > C and SW19 polymorphisms in APOA5 gene and lipid levels in type 2 diabetic patients. Mol Biol Rep 39, 7541– 7548, doi: 10.1007/s11033-012-1588-x (2012). 22350263 · DOI

Cited by

Sorted by citations

Authors
Guan, F., Niu, Y., Zhang, T., Liu, S., Ma, L., Qi, T., Feng, J., Zuo, H., Li, G., Liu, X., & Wang, S.
Affiliations
  • Xi'an Jiaotong University (CN)
  • Washington University in St. Louis (US)
Corresponding author
  • Niu, Yu
  • Wang, Shujin
Venue
Scientific Reports
Published
2016-07-14
Volume
6
Issue
1
Pages
29586-29586
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2475363254
Cited by
72
References
2
Citations by year
2026: 1 · 2025: 2 · 2024: 18 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 16 · 2018: 15 · 2017: 9 · 2016: 2
FWCI
11.30
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by)
Funders
  • National Natural Science Foundation of China (81401563)
  • Ministry of Education of the People's Republic of China (2013021120078)
  • China Postdoctoral Science Foundation (T70927)
  • Shaanxi Province Postdoctoral Science Foundation (201318420005)
  • Fundamental Research Funds for the Central Universities (08143003, 08142024)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
type 2 diabetes, ZPR1, single nucleotide polymorphisms, genetic susceptibility, Han Chinese, haplotype association, fasting blood glucose, HbA1c, glucose metabolism, genotype imputation
MeSH terms
Adult, Aged, Carrier Proteins, China, Diabetes Mellitus, Type 2, Female, Genotype, Humans, Male, Middle Aged, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Membrane Transport Proteins, Asian People, Genetic Association Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review